1
|
Kress HG, Baltov A, Basiński A, Berghea F, Castellsague J, Codreanu C, Copaciu E, Giamberardino MA, Hakl M, Hrazdira L, Kokavec M, Lejčko J, Nachtnebl L, Stančík R, Švec A, Tóth T, Vlaskovska MV, Woroń J. Acute pain: a multifaceted challenge - the role of nimesulide. Curr Med Res Opin 2016; 32:23-36. [PMID: 26414386 DOI: 10.1185/03007995.2015.1100986] [Citation(s) in RCA: 21] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
Abstract
BACKGROUND This article summarizes the outcome from an international consensus meeting, which took place in Vienna on 4 November 2014. SCOPE The aim of the meeting was to provide the state of the art on the pathophysiology and treatment of acute pain with special emphasis on nimesulide, a non-steroidal anti-inflammatory drug (NSAID) indicated for the treatment of acute pain and primary dysmenorrhea. Besides the data on the mechanisms of acute inflammatory pain and on the efficacy and safety of nimesulide in patients affected by different forms of acute pain, the clinical experience of attending experts was discussed based on selected case reports. RESULTS The members of this consensus group recognized that nimesulide is a NSAID highly effective in the treatment of several painful situations with an acute inflammatory component including primary dysmenorrhea. Although safety concerns regarding nimesulide have emerged in recent years, both robust new epidemiological data and clinical experience confirm a positive benefit/risk profile of nimesulide in the treatment of several forms of acute pain. CONCLUSIONS The members of this international consensus group concluded that nimesulide, when used appropriately, remains a particularly valuable and safe option for the treatment of several conditions characterized by the presence of acute inflammatory pain because of the rapid onset of the analgesic action, and the positive evidence-based benefit/risk profile.
Collapse
Affiliation(s)
- H G Kress
- a a Medical University/AKH Vienna - Dept. of Special Anaesthesia and Pain Therapy , Vienna , Austria
| | - A Baltov
- b b Emergency Trauma Hospital 'N.I. Pirogov' -Department of Trauma Surgery , Sofia , Bulgaria
| | - A Basiński
- c c Medical University of Gdańsk, Clinical Emergency Department of the University Clinical Center , Gdańsk , Poland
| | - F Berghea
- d d Clinical Hospital Saint Maria, Carol Davila University of Medicine, Department of Rheumatology , Bucharest , Romania
| | - J Castellsague
- e e RTI Health Solutions International , Barcelona , Spain
| | - C Codreanu
- f f Center of Rheumatic Disease 'Dr. Ion Stoia', Carol Davila University of Medicine, Rheumatology Department , Bucharest , Romania
| | - E Copaciu
- g g University Emergency Hospital, Carol Davila University of Medicine - Anesthesia and Intensive Care Department , Bucharest , Romania
| | - M A Giamberardino
- h h 'G. d'Annunzio' University of Chieti-Pescara - Department of Medicine and Science of Aging , Chieti , Italy
| | - M Hakl
- i i Masaryk University St. Ann's University Hospital - Department of Anesthesiology and Intensive Care Medicine , Brno , Czech Republic
| | - L Hrazdira
- j j Faculty of Sports Studies Masaryk University - Department of Health Support , Brno , Czech Republic
| | - M Kokavec
- k k Orthopedic Department, Children's Faculty Hospital , Bratislava , Slovak Republic
| | - J Lejčko
- l l University Hospital Pilsen - Department of Anaesthesiology and Intensive Care , Plzeň , Czech Republic
| | - L Nachtnebl
- m m Masaryk University St. Anne's University Hospital - 1st Orthopaedics Department , Brno , Czech Republic
| | - R Stančík
- n n Research Institute of Rheumatic Diseases in Piešťany -National Institute of Rheumatic Diseases , Piešťany , Slovak Republic
| | - A Švec
- o o University Hospital Bratislava - First Department of Orthopaedics and Trauma Surgery , Bratislava , Slovak Republic
| | - T Tóth
- p p MÁV PolyClinic - Department of Rheumatology , Debrecen , Hungary
| | - M V Vlaskovska
- q q Medical University of Sofia - Department of Pharmacology and Toxicology , Sofia , Bulgaria
| | - J Woroń
- r r Jagellonian University College of Medicine - Department of Clinical Pharmacology and Department of Pain Treatment and Palliative Care , Kraków , Poland
| |
Collapse
|
2
|
Coriu L, Ungureanu R, Talmaci R, Uscatescu V, Cirstoiu M, Coriu D, Copaciu E. Hereditary Thrombophilia and thrombotic events in pregnancy: single-center experience. J Med Life 2014; 7:567-71. [PMID: 25713624 PMCID: PMC4316141] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/20/2014] [Accepted: 10/20/2014] [Indexed: 11/18/2022] Open
Abstract
Pregnancy is a normal physiological state that predisposes to thrombosis, determined by hormonal changes in the body. These changes occur in the blood flow (venous stasis), changes in the vascular wall (hypotonia, endothelial lesion) and changes in the coagulation factors (increased levels of factor VII, factor VIII, factor X, von Willebrand factor) and decreased activity levels of natural anticoagulants (protein C, protein S). In this study, we tried to determine a possible association between thrombosis and inherited thrombophilia in pregnant women. This is a retrospective study of 151 pregnant women with a history of complicated pregnancy: maternal thrombosis and placental vascular pathology (intrauterine growth restriction, preeclampsia, recurrent pregnancy loss), who were admitted in our hospital during the period January 2010 to July 2014. We performed genetic analyses to detect the factor V Leiden mutation, the G20210A mutation in the prothrombin gene, the C677T mutation and the A1298C mutation in methylenetetrahydrofolate reductase (MTHFR) gene. The risk of thrombosis in patients with factor V Leiden is 2.66 times higher than the patients negative for this mutation (OR 2.66 95% CI 0.96-7.37 P=0.059). We did not find any statistical association with mutations in the MTHFR gene. Pregnant women with a family history of thrombosis present a 2.18-fold higher risk of thrombosis (OR 2.18 CI 0.9-5.26 P=0.085). Of 151 pregnant women, thrombotic events occurred in 24 patients: deep vein thrombosis, pulmonary embolism, cerebral venous sinus thrombosis and ischemic stroke. The occurrence of thrombotic events was identified in the last trimester of pregnancy, but especially postpartum. Thrombosis in pregnancy is a redoubtable complication requiring an excellent cooperation between the obstetrician and anesthesiologist.
Collapse
Affiliation(s)
- L Coriu
- University Emergency Hospital, Bucharest, Romania
| | - R Ungureanu
- University Emergency Hospital, Bucharest, Romania
| | | | | | - M Cirstoiu
- University Emergency Hospital, Bucharest, Romania
| | - D Coriu
- Fundeni Clinical Institute, Romania
| | - E Copaciu
- University Emergency Hospital, Bucharest, Romania
| |
Collapse
|
3
|
Copaciu E, Dumitrascu O, Ursache E, Calin L. 663 MAJOR GENDER DIFFERENCES IN POSTOPERATIVE PAIN SCORES — PROSPECTIVE STUDY IN FOUR UNIVERSITY HOSPITALS. Eur J Pain 2009. [DOI: 10.1016/s1090-3801(09)60666-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
Affiliation(s)
| | | | | | - L. Calin
- University Hospital, Bucharest, Romania
| |
Collapse
|